A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Clinical trial NCT02928406 · COMPLETED

Trial details

NCT number: NCT02928406
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Tract Cancer

Start date: 2016-11-30
Primary completion: 2022-12-12
Enrollment: 1004

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.